Award details

MAP kinase activation and tau phosphorylation in mouse models for Alzheimer's disease

ReferenceBBS/E/B/0000H105
Principal Investigator / Supervisor Dr Lawrence Wilkinson
Co-Investigators /
Co-Supervisors
Institution Babraham Institute
DepartmentBabraham Institute Department
Funding typeResearch
Value (£) 85,034
StatusCompleted
TypeInstitute Project
Start date 01/01/2004
End date 30/06/2007
Duration42 months

Abstract

The project will use transgenic mouse models for Alzheimer¿s disease (AD) developed at the Babraham Institute in order to examine the idea that molecules called MAP kinases play a key role in the way in which a protein called tau is regulated by a chemical process which adds phosphate groups (phosphorylation). This is important because tau function is abnormal in AD and one of the main ways in which it becomes dysfunctional is by its inappropriate phosphorylation.

Summary

unavailable
Committee Closed Committee - Biochemistry & Cell Biology (BCB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file